The Department of Pharmaceuticals issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 on March 13, 2024, with the objective to enhance ethical conduct and bring more transparency to the marketing practices of pharmaceutical companies. Key Features of the Code Attributes Brief Description   Restrictions on Marketing and Promotion of Drugs Drug advertising must […]

Read More →

Foreign Investment in India – Reporting in Single Master Form [RBI/2017-18/194 A. P. Dir. Series Circular No. 30 dated June 07, 2018] RBI has introduced an online reporting user interface, FIRMS (Foreign Investment Reporting and Management System) which would provide for the Single Master Form (SMF). FIRMS would be made online in two phases- In 1st phase, […]

Read More →

MANDATORY REGISTRATION AS LEGAL ENTITY IDENTIFIER (LEI) FOR OTC DERIVATIVES MARKETS The Reserve Bank of India vide its circular RBI/2016-17/314 FMRD.FMID No.14/11.01.007/2016-17 dated June 01, 2017 has mandated the implementation of the LEI system for all participants (existing & future) in the Over-the-Counter (OTC) markets for Rupee Interest Rate derivatives, foreign currency derivatives and credit […]

Read More →

Central Government in continuation of its endeavours to promote Ease of Doing Business in India has passed proposal for abolishing the Foreign Investment Promotion Board (FIPB) and allowing concerned Administrative Ministries/Departments to process applications for FDI requiring government approval. Reduction of formalities and time gap in getting government approvals will make India more attractive destination […]

Read More →

  The Government of India in its endeavour to attract more foreign investment has liberalized FDI policy by enhancing the limit of foreign investment in insurance sector from 26% to 49% under the automatic route subject to certain terms and conditions which have been notified through Press Note No. 1(2016 Series), D/o IPP File No. […]

Read More →